Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations

References

• Izzo, A.A., Teixeira, M., Alexander, S.P.H., Cirino, G., Docherty, J.R., George, C.H., Insel, P.A., Ji, Y., Kendall, D.A., Panattieri, R.A., Sobey, C.G., Stanford, S.C., Stefanska, B., Stephens, G., Ahluwalia, A. (2020). A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research. Br. J. Pharmacol. 177(10): 2169-2178.
   PubMed Web of Science ®Google Scholar
• Semwal, D.K., Badoni, R., Semwal, R., Kothiyal, S.K., Singh, G.J.P., Rawat, U. (2010). The genus Stephania (Menispermaceae): Chemical and pharmacological perspectives. J. Ethnopharmacol. 132(2): 369-383.
   PubMed Web of Science ®Google Scholar
• Desgrouas, C., Taudon, N., Bun, S.S., Baghdikian, B., Bory, S., Parzy, D., Ollivier, E. (2014). Ethnobotany, phytochemistry and pharmacology of Stephania rotunda Lour. J. Ethnopharmacol. 154(3): 537-563.
   PubMed Web of Science ®Google Scholar
• Hong, L., Guo, Z., Huang, K., Wei, S., Liu, B., Meng, S., Long, C. (2015). Ethnobotanical study on medicinal plants used by Maonan people in China. J. Ethnobiol. Ethnomed. 11(1): 1-35.
   PubMedGoogle Scholar
• Patra, A., Freyer, A.J., Shamma, M., Guinaudeau, H., Tantisewie, B., Pharadai, K. (1986). The Bisbenzylisoquinoline Alkaloids of Stephania Suberosa. J. Nat. Prod. 49(3): 424-427.
   Web of Science ®Google Scholar
• Lv, J.J., Xu, M., Wang, D., Zhu, H.T., Yang, C.R., Wang, Y.F., Li, Y., Zhang, Y.J. (2013). Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea. J. Nat. Prod. 76(5): 926-932.
   PubMed Web of Science ®Google Scholar
• Tantisewie, B., Amurrio, S., Guinaudeau, H., Shamma, M. (1989). New Bisbenzylisoquinolines from Stephania pierrii. J. Nat. Prod. 52(4): 846-851.
   Web of Science ®Google Scholar
• Haddaway, N.R., Page, M.J., Pritchard, C.C., McGuinness, L.A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst. Rev. 18(2).
   Google Scholar
• Bailly, C. (2019). Cepharanthine: An update of its mode of action, pharmacological properties and medical applications. Phytomedicine. 62: 152956.
   PubMed Web of Science ®Google Scholar
• Rogosnitzky, M., Danks, R. (2011). Therapeutic potential of the biscoclaurine alkaloid, cepharan-thine, for a range of clinical conditions. Pharm-acol. Reports. 63(2): 337-347.
   PubMed Web of Science ®Google Scholar
• Liang, D., Li, Q., Du, L., Dou, G. (2022). Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules. 27(24): 8933.
   PubMed Web of Science ®Google Scholar
• Weber, C., Opatz, T. (2019). Bisbenzyliso-quinoline Alkaloids. lkaloids Chem. Biol. 81: 1-114.
   Google Scholar
• Wang, Y., Zhou, X., Wei, S., Wang, G., Xi, J. (2023). Current status and future challenges in extraction, purification and identification of Cepharanthine (a potential drug against COVID-19). Sep. Purif. Technol. 309: 123038.
   PubMed Web of Science ®Google Scholar
• Kikukawa, Y., Okuno, Y., Tatetsu, H., Nakamura, M., Harada, N., Ueno, S., Kamizaki, Y., Mitsuya, H., Hata, H. (2008). Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid. Int. J. Oncol. 33(4): 807-14. http://www.ncbi.nlm.nih.gov/pubmed/18813795
   PubMed Web of Science ®Google Scholar
• Rogosnitzky, M., Okediji, P., Koman, I. (2020). Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacol. Reports. 72(6): 1509-1516.
   PubMed Web of Science ®Google Scholar
• Deng, Y., Wu, W., Ye, S., Wang, W., Wang, Z. (2017). Determination of cepharanthine in rat plasma by LC–MS/MS and its application to a pharmacokinetic study. Pharm. Biol. 55(1): 1775-1779.
   PubMed Web of Science ®Google Scholar
• Jain, D., Hossain, R., Ahmed Khan, R., Dey, D., Rahman Toma, T., Torequl Islam, M., Janmeda, P., Rehman Hakeem, K. (2021). Computer-aided Evaluation of Anti-SARS-CoV-2 (3-chymotrypsin-like Protease and Trans-membrane Protease Serine 2 Inhibitors) Activity of Cepharanthine: An In silico Approach. Biointerface Res. Appl. Chem. 12(1): 768-780.
   Web of Science ®Google Scholar
• Cepharanthine oral disintegration tablet and its preparing method. (2005). https://patents.google.com/patent/CN100387226C/en
   Google Scholar
• Zhao, W., Yao, D., Yang, R., Huo, H., Qin, C., Sun, K. (2021). A molecular docking study: Cepharanthine protects articular cartilage against arthritis by Wnt/PI3K/TLR-3 signaling. Arab. J. Chem. 14(2): 102883.
   Web of Science ®Google Scholar
• Aota, K., Yamanoi, T., Kani, K., Azuma, M. (2018). Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Sig-nal Pathway in Human Salivary Gland Ductal Cells. Inflammation. 41(1): 50-58.
   PubMed Web of Science ®Google Scholar
• Kudo, K., Hagiwara, S., Hasegawa, A., Kusaka, J., Koga, H., Noguchi, T. (2011). Cepharanthine Exerts Anti-Inflammatory Effects Via NF-κB Inhibition in a LPS-Induced Rat Model of Systemic Inflammation. J. Surg. Res. 171(1): 199-204.
   PubMed Web of Science ®Google Scholar
• Huang, H., Hu, G., Wang, C., Xu, H., Chen, X., Qian, A. (2014). Cepharanthine, an Alkaloid from Stephania cepharantha Hayata, Inhibits the Inflammatory Response in the RAW264.7 Cell and Mouse Models. Inflammation. 37(1): 235-246.
   PubMed Web of Science ®Google Scholar
• Ershun, Z., Yunhe, F., Zhengkai, W., Yongguo, C., Naisheng, Z., Zhengtao, Y. (2014). Cepharanthine Attenuates Lipopolysaccharide-Induced Mice Mastitis by Suppressing the NF-κB Signaling Pathway. Inflammation. 37(2): 331-337.
   PubMed Web of Science ®Google Scholar
• Gao, S., Zhou, L., Lu, J., Fang, Y., Wu, H., Xu, W., Pan, Y., Wang, J., Wang, X., Zhang, J., Shao, A. (2022). Cepharanthine Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Mice via Inhibiting 15-Lipoxygenase-1-Mediated Microglia and Endothelial Cell Ferroptosis.Tang H, editor. Oxid. Med. Cell. Longev. 2022: 1-16.
   Web of Science ®Google Scholar
• Cierluk, K., Szlasa, W., Rossowska, J., Tarek, M., Szewczyk, A., Saczko, J., Kulbacka, J. (2020). Cepharanthine induces ROS stress in glioma and neuronal cells via modulation of VDAC permeability. Saudi Pharm. J. 28(11): 1364-1373.
   PubMed Web of Science ®Google Scholar
• Chen, M.L., Gou, J.M., Meng, X.L., Chen, C.L., Liu, X.N. (2019). Cepharanthine, a bisbenzylisoquinoline alkaloid, inhibits lipopoly-saccharide-induced microglial activation. Pharmazie. 74(10): 606-610.
   PubMed Web of Science ®Google Scholar
• Wu, Y., Cao, Y., Wang, S., Xu, X., Wang, M. (2019). Cepharanthine promotes the effect of dexmedetomidine on the deposition of β-amyloid in the old age of the senile dementia rat model by regulating inflammasome expression. Folia Neuropathol. 57(4): 348-356.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Tang, Q., Rao, Z., Fang, Y., Jiang, X., Liu, W., Luan, F., Zeng, N. (2021). Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING/TBK1/P62 pathway. Antiviral Res. 193: 105143.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Chen, L., Liu, W., Li, D., Zeng, J., Tang, Q., Zhang, Y., Luan, F., Zeng, N. (2021). Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways. Front. Microbiol. 12: 3685.
   Web of Science ®Google Scholar
• Baba, M., Okamoto, M., Kashiwaba, N., Ono, M. (2001). Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells. Antivir. Chem. Chemother. 12(5): 307-312.
   PubMed Web of Science ®Google Scholar
• Phumesin, P., Panaampon, J., Kariya, R., Limjindaporn, T., Yenchitsomanus, P., Okada, S. (2023). Cepharanthine inhibits dengue virus production and cytokine secretion. Virus Res. 325: 199030.
   PubMed Web of Science ®Google Scholar
• Wei, J., Pan, S., Liu, S., Qian, B., Shen, Z., Zhang, Y., Bian, Y., ABuduaini, Ad., Dong, F., Zhang, X., et al. (2023). Safety and Efficacy of Oral administrated Cepharanthine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial. medRxiv. 1-21.
   Google Scholar
• Fan, H., He, S., Han, P., Hong, B., Liu, K., Li, M., Wang, S., Tong, Y. (2022). Cepharanthine: A Promising Old Drug against SARS-CoV-2. Adv. Biol. 6(12).
   Google Scholar
• Jiang, P., Ye, J., Jia, M., Li, X., Wei, S., Li, N. (2022). The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19. Front. Pharmacol. 13: 960267.
   PubMed Web of Science ®Google Scholar
• Samra, Y.A., Said, H.S., Elsherbiny, N.M., Liou, G.I., El-Shishtawy, M.M., Eissa, L.A. (2016). Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome. Life Sci. 157: 187-199.
   PubMed Web of Science ®Google Scholar
• Kuna, L., Jakab, J., Smolic, R., Raguz-Lucic, N., Vcev, A., Smolic, M. (2019). Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options. J. Clin. Med. 8(2): 179.
   PubMed Web of Science ®Google Scholar
• Zhang, M.-N., Xie, R., Wang, H.-G., Wen, X., Wang, J.-Y., He, L., Zhang, M.-H., Yang, X.-Z. (2023). Cepharanthine Alleviates DSS-Induced Ulcerative Colitis via Regulating Aconitate Decarboxylase 1 Expression and Macrophage Infiltration. Molecules. 28(3): 1060.
   PubMed Web of Science ®Google Scholar
• Wang, H.G., Zhang, M.N., Wen, X., He, L., Zhang, M.H., Zhang, J.L., Yang, X.Z. (2022). Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota. Microb. Biotechnol. 15(8): 2208-2222.
   PubMed Web of Science ®Google Scholar
• Shen, S., Prame Kumar, K., Stanley, D., Moore, R.J., Van, T.T.H., Wen, S.W., Hickey, M.J., Wong, C.H.Y. (2018). Invariant Natural Killer T Cells Shape the Gut Microbiota and Regulate Neutrophil Recruitment and Function During Intestinal Inflammation. Front. Immunol. 9: 999.
   PubMed Web of Science ®Google Scholar
• Hosomi, S., Oshitani, N., Kamata, N., Sogawa, M., Okazaki, H., Tanigawa, T., Yamagami, H., Watanabe, K., Tominaga, K., Watanabe, T., Fujiwara, Y., Maeda, K., Hirakawa, K., Arakawa, T. (2011). Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clin. Exp. Immunol. 163(2): 215-224.
   PubMed Web of Science ®Google Scholar
• He, J., Song, Y., Li, G., Xiao, P., Liu, Y., Xue, Y., Cao, Q., Tu, X., Pan, T., Jiang, Z., Cao, X., Lai, L., Wang, Q. (2019). Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation. J. Clin. Invest. 129(9): 3877-3893.
   PubMed Web of Science ®Google Scholar
• Iijima, N., Mattei, L.M., Iwasaki, A. (2011). Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc. Natl. Acad. Sci. 108(1): 284-289.
   PubMed Web of Science ®Google Scholar
• Billmeier, U., Dieterich, W., Neurath, M.F., Atreya, R. (2016). Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J. Gastroenterol. 22(42): 9300.
   PubMed Web of Science ®Google Scholar
• Vancheri, C., Failla, M., Crimi, N., Raghu, G. (2010). Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur. Respir. J. 35(3): 496-504.
   PubMed Web of Science ®Google Scholar
• Aimo, A., Spitaleri, G., Nieri, D., Tavanti, L.M., Meschi, C., Panichella, G., Lupón, J., Pistelli, F., Carrozzi, L., Bayes-Genis, A., Emdin, M. (2022). Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond. Card. Fail. Rev. 8: e12.
   PubMedGoogle Scholar
• Liu, P., Miao, K., Zhang, L., Mou, Y., Xu, Y., Xiong, W., Yu, J., Wang, Y. (2020). Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation. Respir. Res. 21(1): 1-10.
   PubMed Web of Science ®Google Scholar
• Chen, G., Li, J., Liu, H., Zhou, H., Liu, M., Liang, D., Meng, Z., Gan, H., Wu, Z., Zhu, X., Han, P., Liu, T., Gu, R., Liu, S., Dou, G. (2023). Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules. 28(2): 753.
   PubMed Web of Science ®Google Scholar
• Fuster, J.J., Fernández, P., González-Navarro, H., Silvestre, C., Nabah, Y.N.A., Andrés, V. (2010). Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc. Res. 86(2): 254-264.
   PubMed Web of Science ®Google Scholar
• Paudel, K.R., Karki, R., Kim, D.-W. (2016). Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Toxicol. Vitr. 34: 16-25.
   PubMed Web of Science ®Google Scholar
• Baker, C.S.R., Hall, R.J.C., Evans, T.J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M.H., Polak, J.M. (1999). Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler. Thromb. Vasc. Biol. 19(3): 646-655.
   PubMed Web of Science ®Google Scholar
• Li, P.-C., Sheu, M.-J., Ma, W.-F., Pan, C.-H., Sheu, J.-H., Wu, C.-H. (2015). Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells. Mar. Drugs. 13(5): 3046-3060.
   PubMed Web of Science ®Google Scholar
• Kalogeris, T., Baines, C.P., Krenz, M., Korthuis, R.J. (2012). Cell Biology of Ischemia/Reperfusion Injury. Int. Rev. Cell Mol. Biol. 298: 229-317.
   PubMed Web of Science ®Google Scholar
• Kusaka, J., Hagiwara, S., Hasegawa, A., Kudo, K., Koga, H., Noguchi, T. (2011). Cepharanthine Improves Renal Ischemia-Reperfusion Injury in Rats. J. Surg. Res. 171(1): 212-217.
   PubMed Web of Science ®Google Scholar
• Kao, M.C., Yang, C.H., Chou, W.C., Sheu, J.R., Huang, C.J. (2015). Cepharanthine mitigates lung injury in lower limb ischemia–reperfusion. J. Surg. Res. 199(2): 647-656.
   PubMed Web of Science ®Google Scholar
• Zhao, J., Piao, X., Wu, Y., Liang, S., Han, F., Liang, Q., Shao, S., Zhao, D. (2020). Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling. Biomed. Pharmacother. 127: 110151.
   PubMed Web of Science ®Google Scholar
• Chang, Y.K., Huang, S.C., Kao, M.C., Huang, C.J. (2016). Cepharanthine alleviates liver injury in a rodent model of limb ischemia–reperfusion. Acta Anaesthesiol. Taiwanica. 54(1):1 1-15.
   PubMedGoogle Scholar
• Iqbal, A., Najam, R., Simjee, S., Athar Ishaqui, A., Ashfaq Ahmad, S., Ahmed, Z., Ahmed, S., Ahmed, S., Jaweed, L., Maboos, M., Muhammad Uzairullah, M., Jabeen, S., Imran, M. (2022). Cepharanthine action in preventing obesity and hyperlipidemia in rats on a high-fat high sucrose diet. Saudi Pharm. J. 30(12): 1683-1690.
   PubMed Web of Science ®Google Scholar
• Zhou, P., Li, Z., Xu, D., Wang, Y., Bai, Q., Feng, Y., Su, G., Chen, P., Wang, Y., Liu, H., Wang, X., Zhang, R., Wang, Y. (2019). Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice. Front. Cell. Infect. Microbiol. 9: 225.
   PubMed Web of Science ®Google Scholar
• Uto, T., Nishi, Y., Toyama, M., Yoshinaga, K., Baba, M. (2011). Inhibitory effect of cepharanthine on dendritic cell activation and function. Int. Immunopharmacol. 11(11): 1932–1938
   PubMed Web of Science ®Google Scholar
• Zhou, C., Meng, J., Yang, Y., Hu, B., Hong, J., Lv, Z., Chen, K., Heng, B.C., Jiang, G., Zhu, J., Cheng, Z., Zhang, W., Cao, L., Wang, W., Shen, W., Yan, S., Wu, H. (2018). Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption. Front. Pharmacol. 9: 210.
   PubMed Web of Science ®Google Scholar
• Karki, R., Man, S.M., Malireddi, R.K.S., Kesavardhana, S., Zhu, Q., Burton, A.R., Sharma, B.R., Qi, X., Pelletier, S., Vogel, P., Rosenstiel, P., Kanneganti, T.-D. (2016). NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer. Nature. 540(7634): 583-587.
   PubMed Web of Science ®Google Scholar
• Baron, R., Neff, L., Roy, C., Boisvert, A., Caplan, M. (1986). Evidence for a high and specific concentration of (Na+,K+)ATPase in the plasma membrane of the osteoclast. Cell. 46(2): 311-320.
   Google Scholar
• Lin, X., Song, F., Zhou, L., Wang, Z., Wei, C., Xu, J., Zhao, J., Liu, Q. (2019). Cepharanthine suppresses osteoclast formation by modulating the nuclear factor-κB and nuclear factor of activated T-cell signaling pathways. J. Cell. Biochem. 120(2): 1990-1996.
   PubMed Web of Science ®Google Scholar
• Lun E. Hon, K., K.C. Leung, A. (2011). Alopecia Areata. Recent Pat. Inflamm. Allergy Drug Discov. 5(2): 98-107.
   PubMedGoogle Scholar
• Ou, H.C., Cunningham, L.L., Francis, S.P., Brandon, C.S., Simon, J.A., Raible, D.W., Rubel, E.W. (2009). Identification of FDA-Approved Drugs and Bioactives that Protect Hair Cells in the Zebrafish (Danio rerio) Lateral Line and Mouse (Mus musculus) Utricle. J. Assoc. Res. Otolaryngol. 10(2): 91-203.
   PubMed Web of Science ®Google Scholar
• Inui, S., Itami, S. (2013). Induction of insulin-like growth factor-I by cepharanthine from dermal papilla cells: a novel potential pathway for hair growth stimulation. J. Dermatol. 40(12): 1054-1055.
   PubMed Web of Science ®Google Scholar
• Inui, S., Tohyama, C., Itami, S. (2016). Acceleration of Hair Growth Rate by Topical Liposomal Cepharanthine in Male Androgenetic Alopecia. Hair Ther. Transplant. 06(02): 145.
   Google Scholar
• Carbone, A. (2020). Cancer Classification at the Crossroads. Cancers (Basel). 12(4):980.
   PubMedGoogle Scholar
• Saini, A., Kumar, M., Bhatt, S., Saini, V. (2020). Cancer Causes and Treatments. Int. J. Pharm. Sci. Res. 11(7): 3121-3134.
   Web of Science ®Google Scholar
• Siegel, R.L., Miller, K.D., Wagle, N.S., Jemal, A. (2023). Cancer statistics, 2023. CA. Cancer J. Clin. 73(1): 17-48.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. (2018). Global Cancer Facts & Figures 4th Edition. Atlanta: American Cancer Society.
   Google Scholar
• Debela, D.T., Muzazu, S.G.Y., Heraro, K.D., Ndalama, M.T., Mesele, B.W., Haile, D.C., Kitui, S.K., Manyazewal, T. (2021). New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 9: 205031212110343.
   Web of Science ®Google Scholar
• Shahriyar, S., Woo, S., Seo, S., Min, K., Kwon, T. (2018). Cepharanthine Enhances TRAIL-Mediated Apoptosis Through STAMBPL1-Mediated Downregulation of Survivin Expression in Renal Carcinoma Cells. Int. J. Mol. Sci. 19(10): 3280.
   PubMed Web of Science ®Google Scholar
• Xu, W., Wang, X., Tu, Y., Masaki, H., Tanaka, S., Onda, K., Sugiyama, K., Yamada, H., Hirano, T. (2019). Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells. Chem. Biol. Interact. 310: 108726.
   PubMed Web of Science ®Google Scholar
• Huang, C.Z., Wang, Y.F., Zhang, Y., Peng, Y.M., Liu, Y.X., Ma, F., Jiang, J.H., Wang, Q.D. (2017). Cepharanthine hydrochloride reverses P-glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway. Oncol. Rep. 38(4): 2558-2564.
   PubMed Web of Science ®Google Scholar
• Zhu, Q., Guo, B., Chen, L., Ji, Q., Liang, H., Wen, N., Zhang, L. (2017). Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation. Oncol. Lett. 13(5): 3760-3766.
   PubMed Web of Science ®Google Scholar
• Li, G., Qiao, K., Xu, X., Wang, C. (2022). Cepharanthine Regulates Autophagy via Activating the p38 Signaling Pathway in Lung Adenocarcinoma Cells. Anticancer. Agents Med. Chem. 22(8): 1523-1529.
   PubMed Web of Science ®Google Scholar
• Gui-Feng, S., Ze-Xiu, H., Deng-Liang, H., Peng-Xiao, C., Yao, W., Yi-Fei, W. (2022). Cepharanthine hydrochloride inhibits the Wnt/β-catenin/Hedgehog signaling axis in liver cancer. Oncol. Rep. 47(4): 1-11.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Zhang, G., Zhao, Z., Xiu, R., Jia, J., Chen, P., Liu, Y., Wang, Y., Yi, J. (2021). Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy. Biochim. Biophys. Acta - Mol. Cell Res. 1868(12): 119132.
   PubMed Web of Science ®Google Scholar
• Feng, F., Pan, L., Wu, J., Li, L., Xu, H., Yang, L., Xu, K., Wang, C. (2021). Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo. Int. J. Biol. Sci. 17(15): 4340-4352.
   PubMed Web of Science ®Google Scholar
• Payon, V., Kongsaden, C., Ketchart, W., Mutirangura, A., Wonganan, P. (2019). Mecha-nism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells. Planta Med. 85(1): 41-47.
   PubMed Web of Science ®Google Scholar
• Weiss, D.S., Raupach, B., Takeda, K., Akira, S., Zychlinsky, A. (2004). Toll-Like Receptors Are Temporally Involved in Host Defense. J. Immunol. 172(7): 4463-4469.
   PubMed Web of Science ®Google Scholar
• Tang, Z.H., Cao, W.X., Guo, X., Dai, X.Y., Lu, J.H., Chen, X., Zhu, H., Lu, J.J. (2018). Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer. Cancer Lett. 412: 1-9.
   PubMed Web of Science ®Google Scholar
• Kwon, H.J., Abi-Mosleh, L., Wang, M.L., Deisenhofer, J., Goldstein, J.L., Brown, M.S., Infante, R.E. (2009). Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol. Cell. 137(7): 1213-1224.
   PubMed Web of Science ®Google Scholar
• Liu, L., Parent, C.A. (2011). TOR kinase complexes and cell migration. J. Cell Biol. 194(6): 815-824.
   PubMed Web of Science ®Google Scholar
• Lyu, J., Yang, E.J., Head, S.A., Ai, N., Zhang, B., Wu, C., Li, R.-J., Liu, Y., Yang, C., Dang, Y., Kwon, H.J., Ge, W., Liu, J.O., Shim, J.S. (2017). Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth. Cancer Lett. 409: 91-103.
   PubMed Web of Science ®Google Scholar
• Rattanawong, A., Payon, V., Limpanasittikul, W., Boonkrai, C., Mutirangura, A., Wonganan, P. (2018). Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1. Oncol. Rep. 39(1): 227-238.
   PubMed Web of Science ®Google Scholar
• Unson, S., Kongsaden, C., Wonganan, P. (2020). Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells. J. Asian Nat. Prod. Res. 22(4): 370-385.
   PubMed Web of Science ®Google Scholar
• Gao, S., Li, X., Ding, X., Qi, W., Yang, Q. (2017). Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells. Cell. Physiol. Biochem. 41(4): 1633-1648.
   PubMedGoogle Scholar
• Chen, Z., Huang, C., Yang, Y., Ding, Y., Ou-Yang, H., Zhang, Y., Xu, M. (2012). Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells. Acta Pharmacol. Sin. 33(1): 101-108.
   PubMed Web of Science ®Google Scholar
• Hua, P., Sun, M., Zhang, G., Zhang, Y., Tian, X., Li, X., Cui, R., Zhang, X. (2015). Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Biochem. Biophys. Res. Commun. 460(2): 136-142.
   PubMed Web of Science ®Google Scholar
• Uthaisar, K., Seubwai, W., Srikoon, P., Vaeteewoottacharn, K. (2012). Cepharanthine Suppresses Metastatic Activity of Cholangiocarcinoma Cells Asian Pacific. Asian Pacific J. Cancer Prev. 13: 149-154.
   PubMedGoogle Scholar
• Liu, G., Wu, D., Liang, X., Yue, H., Cui, Y. (2015). Mechanisms and in vitro effects of cepharanthine hydrochloride: Classification analysis of the drug-induced differentially-expressed genes of human nasopharyngeal carcinoma cells. Oncol. Rep. 34(4): 2002-2010.
   PubMed Web of Science ®Google Scholar
• Seubwai, W., Vaeteewoottacharn, K., Hiyoshi, M., Suzu, S., Puapairoj, A., Wongkham, C., Okada, S., Wongkham, S. (2010). Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB. Cancer Sci. 101(7): 1590-1595.
   PubMed Web of Science ®Google Scholar
• Takahashi-Makise, N., Suzu, S., Hiyoshi, M., Ohsugi, T., Katano, H., Umezawa, K., Okada, S. (2009). Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-κB pathway. Int. J. Cancer. 125(6): 1464-1472.
   PubMed Web of Science ®Google Scholar
• Harada, K., Supriatno, Yamamoto, S., Kawaguchi, S.-I., Yoshida, H., Sato, M. (2003). Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1. Anticancer Res. 23(2B): 1441-8.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Jiang, X., Deng, Q., Gao, Z., Tang, X., Fu, R., Hu, J., Li, Y., Li, L., Gao, N. (2019). Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network. J. Exp. Clin. Cancer Res. 38(1): 1-18.
   PubMed Web of Science ®Google Scholar
• Shen, L., Jiang, X., Li, Z., Li, J., Wang, M., Jia, G., Ding, X., Lei, L., Gong, Q., Gao, N. (2022). Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis. Acta Pharmacol. Sin. 43(1): 177-193.
   PubMed Web of Science ®Google Scholar
• Luo, J., Liu, D. (2020). Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo? Front. Endocrinol. (Lausanne). 11(148): 515000.
   Google Scholar
• Wang, Y., Su, G.-F., Huang, Z.-X., Wang, Z.-G., Zhou, P.-J., Fan, J.-L., Wang, Y.-F. (2020). Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC). Expert Opin. Ther. Targets. 24(4): 389-402.
   PubMed Web of Science ®Google Scholar
• Li, S., Song, Y., Quach, C., Guo, H., Jang, G.-B., Maazi, H., Zhao, S., Sands, N.A., Liu, Q., In, G.K., et al. (2019). Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance. Nat. Commun. 10(1): 1693.
   PubMedGoogle Scholar
• Girotti, M.R., Fernández, M., López, J.A., Camafeita, E., Fernández, E.A., Albar, J.P., Benedetti, L.G., Valacco, M.P., Brekken, R.A., Podhajcer, O.L., Llera, A.S. (2011). SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis. J. Invest. Dermatol. 131(12): 2438-2447.
   PubMed Web of Science ®Google Scholar
• Qifan, W., Fen, N., Ying, X., Xinwei, F., Jun, D., Ge, Z. (2016). iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice. Tumor Biol. 37(8): 10643-10652.
   PubMedGoogle Scholar
• Liu, Y., Xie, Y., Lin, Y., Xu, Q., Huang, Y., Peng, M., Lai, W., Zheng, Y. (2020). Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins. Front. Bioeng. Biotechnol. 8: 1295.
   Web of Science ®Google Scholar
• Shukla, S., Shishodia, G., Mahata, S., Hedau, S., Pandey, A., Bhambhani, S., Batra, S., Basir, S.F., Das, B.C., Bharti, A.C. (2010). Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: Implications in high-risk human papillomavirus infection. Mol. Cancer. 9(1): 1-17.
   PubMedGoogle Scholar
• Fang, Z.H., Li, Y.J., Chen, Z., Wang, J.J., Zhu, L.H. (2013). Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells. Int. J. Gynecol. Cancer. 23(4): 608-614.
   PubMed Web of Science ®Google Scholar
• Uto, T., Toyama, M., Yoshinaga, K., Baba, M. (2016). Cepharanthine induces apoptosis through the mitochondria/caspase pathway in murine dendritic cells. Immunopharmacol. Immunotoxicol. 38(3): 238-243.
   PubMed Web of Science ®Google Scholar
• Harada, K., Ferdous, T., Itashiki, Y., Takii, M., Mano, T., Mori, Y., Ueyama, Y. (2009). Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8. Int. J. Oncol. 35(5): 1025-1035.
   PubMed Web of Science ®Google Scholar
• Harada, K., Ferdous, T., Itashiki, Y., Takii, M., Mano, T., Mori, Y., Ueyama, Y. (2009). Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Anticancer Res. 29(4): 1263-70.
   PubMed Web of Science ®Google Scholar
• Guo, Z., Jiang, C.-H., Tong, C., Yang, Y., Wang, Z., Lam, S.M., Wang, D., Li, R., Shui, G., Shi, Y.S., Liu, J.-J. (2022). Activity-dependent PI4P synthesis by PI4KIIIα regulates long-term synaptic potentiation. Cell Rep. 38(9): 110452.
   PubMed Web of Science ®Google Scholar
• Jiang, X., Huang, X., Zheng, G., Jia, G., Li, Z., Ding, X., Lei, L., Yuan, L., Xu, S., Gao, N. (2022). Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis. Theranostics. 12(16): 6972.
   PubMed Web of Science ®Google Scholar
• Zhou, P., Zhang, R., Wang, Y., Xu, D., Zhang, L., Qin, J., Su, G., Feng, Y., Chen, H., You, S., Rui, W., Liu, H., Chen, S., Chen, H., Wang, Y. (2017). Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)- mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget. 8(67): 111144-111160.
   PubMedGoogle Scholar
• Zhou, P., Zhang, R., Wang, Y., Xu, D., Zhang, L., Qin, J., Su, G., Feng, Y., Chen, H., You, S., Rui, W., Liu, H., Chen, S., Chen, H., Wang, Y. (2021). Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget. 12(1): 61-62.
   PubMedGoogle Scholar
• Zhou, Y., Hopper-Borge, E., Shen, T., Huang, X.C., Shi, Z., Kuang, Y.H., Furukawa, T., Akiyama, S. ichi, Peng, X.X., Ashby, C.R., Chen, X., Kruh, G.D., Chen, Z.S. (2009). Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochem. Pharmacol. 77(6): 993-1001.
   PubMed Web of Science ®Google Scholar
• Li, H., Yan, Z., Ning, W., Xiao-Juan, G., Cai-Hong, Z., Jin-Hua, J., Fang, M., Qing-Duan, W. (2011). Using Rhodamine 123 Accumulation in CD 8+ Cells as a Surrogate Indicator to Study the P-Glycoprotein Modulating Effect of Cepharanthine Hydrochloride In Vivo. J. Biomed. Biotechnol. 2011: 1-7.
   Google Scholar
• Ouellette, M.M., Zhou, S., Yan, Y. (2022). Cell Signaling Pathways That Promote Radio-resistance of Cancer Cells. Diagnostics. 12(3): 656.
   Web of Science ®Google Scholar
• Xia, S., Zhao, Y., Yu, S., Zhang, M. (2010). Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. Cancer Biother. Radiopharm. 25(3): 317-323.
   PubMed Web of Science ®Google Scholar
• Harada, T., Harada, K., Ueyama, Y. (2012). The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma. Int. J. Oncol. 41(2): 565-572.
   PubMed Web of Science ®Google Scholar
• Tamatani, T., Azuma, M., Motegi, K., Takamaru, N., Kawashima, Y., Bando, T. (2007). Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-κB activity in human oral squamous cell carcinoma cells. Int. J. Oncol. 31(4): 761-768.
   PubMed Web of Science ®Google Scholar
• Hoshyar, N., Gray, S., Han, H., Bao, G. (2016). The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 11(6):673-692.
   PubMed Web of Science ®Google Scholar
• Gao, P., Jiang, Z., Luo, Q., Mu, C., Cui, M., Yang, X. (2021). Preparation and Evalua-tion of Self-emulsifying Drug Delivery System (SEDDS) of Cepharanthine. AAPS PharmSciTech. 22(7): 245.
   PubMed Web of Science ®Google Scholar
• Lu, C., Zheng, J., Ding, Y., Meng, Y., Tan, F., Gong, W., Chu, X., Kong, X., Gao, C. (2021). Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy. Drug Deliv. 28(1): 2582-2593.
   PubMed Web of Science ®Google Scholar
• Li, Q., Cai, T., Huang, Y., Zhang, R., Cole, S.P.C., Cai, Y. (2017). The preparation and evaluation of cepharanthine- nanostructured lipid carriers in vitro and in vivo. J. Biomater. Tissue Eng. 7(9): 848-857.
   Web of Science ®Google Scholar
• Zhao, Y., Fu, T., Meng, G., Qiao, F., Hou, Y., Liu, Y., Yang, J. (2020). Characterization of cepharanthin nanosuspensions and evaluation of their In vitro activity for the HepG2 hepatocellular carcinoma cell line. Anticancer. Agents Med. Chem. 20(18): 2293-2303.
   PubMed Web of Science ®Google Scholar
• Yu, H.-H., Mi, W.-N., Liu, B., Zhao, H.-P. (2016). In vitro and in vivo effect of paclitaxel and cepharanthine co-loaded polymeric nano-particles in gastric cancer. J. BUON. 21(1): 125-34.
   PubMed Web of Science ®Google Scholar
• Shen, Y., Ai, J., Lin, N., Zhang, H., Li, Y., Wang, H., Wang, S., Wang, Z., Li, T., Sun, F., et al. (2022). An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants. Emerg. Microbes Infect. 11(1): 518-1523.
   Web of Science ®Google Scholar
• Yamazaki, T., Shibuya, A., Ishii, S., Miura, N., Ohtake, A., Sasaki, N., Araki, R., Ota, Y., Fujiwara, M., Miyajima, Y., et al. (2017). High-dose Cepharanthin for pediatric chronic immune thrombocytopenia in Japan. Pediatr. Int. 59(3): 303-308.
   PubMed Web of Science ®Google Scholar
• Uchiyama, Y., Murakami, S., Kakimoto, N., Nakatani, A., Furukawa, S. (2005). Effectiveness of Cepharanthin in decreasing interruptions during radiation therapy for oral cancer. Oral Radiol. 21(1): 41-44.
   Google Scholar
• Desgrouas, C., Chapus, C., Desplans, J., Travaille, C., Pascual, A., Baghdikian, B., Ollivier, E., Parzy, D., Taudon, N. (2014). In vitro antiplasmodial activity of cepharanthine. Malar. J. 13(1): 1-11.
   PubMedGoogle Scholar
• Biswas, K.K., Tancharon, S., Sarker, K.P., Kawahara, K.I., Hashiguchi, T., Maruyama, I. (2006). Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett. 580(2): 703-710.
   PubMed Web of Science ®Google Scholar